08.03.18
France
ww.pierre-fabre.com
Sales: $1.5 billion for cosmetics. Corporate sales: $2.5 billion.
Key Personnel: Pierre-Yves Revol, chairman of the Pierre Fabre Foundation; Eric Ducournau, group chief executive officer; Frédéric Duchesne, chief executive officer, pharmaceuticals; Eric Gouy, senior vice president, finance; Marc Alias, director, corporate communications; Thierry Denjean, senior vice president, human resources, ethics and sustainable development; Olivier Siegler, director of the digital, processes and organization corporate department; Michael Danon, senior vice president, legal, pharmaceutical and public affairs.
Major Products: Skin care and hair care. Brands Pierre Fabre, Ducray, Eau Thermale Avene, A-Derma, Klorane, Elancyl, Galenic, Rene Furterer, Darrow and Glytone. The company’s consumer health care division offers products relating to consumer health care, oral care and natural health, including phytotherapy and aromatherapy.
Comments: There’s a new person in the c-suite at Pierre Fabre Group; Eric Ducournau is now chief executive officer taking over for Bertrand Parmentier, who retired. Ducournau, who officially took over the post on July 2, had been CEO of Pierre Fabre Dermo-Cosmetics since October 2012. He joined the company in 2000.
This year, Pierre Fabre Dermo-Cosmetics signed a partnership in which it became the second investor in Même, a start-up brand that offers cosmetics for women suffering from cancer. The range—which was created by two young women inspired by their own personal experience—was formulated in collaboration with oncologists and dermatologists. According to Pierre Fabre, sales teams and medical reps of Eau Thermale Avène will help build recognition of Même products in oncology departments and pharmacies.
Last year, the Pierre Fabre group officially opened a renovated Péraudel site in Castres France, which is home to the group’s Consumer Health Care division. The unit, which is responsible for several OTC health products as well as oral care SKUs, natural health products, phytotherapy and aromatherapy, generated revenue of about $333 million in 2016. The renovation of the three-story building represented an investment of about $13 million.
Pierre Fabre’s clinical research and development center, located at the Hôtel-Dieu-Saint-Jacques in Toulouse, studies the physiology of normal skin and the biological, physico-chemical and mechanical mechanisms involved in skin disorders. Nearly 900 clinical studies are conducted at the site each year.
The Fabre name can be found on places other than skin care labs; the rugby stadium in Castres was recently renamed after Pierre Fabre, who was an avid fan of the sport.
In the US, the Klorane Botanical Foundation and national non-profit KidsGardening recently named six schools as winners of the inaugural Budding Botanist Grant. The grant, valued at $3000 in cash and supplies, is provided to school educators at inner city, low-income schools.
ww.pierre-fabre.com
Sales: $1.5 billion for cosmetics. Corporate sales: $2.5 billion.
Key Personnel: Pierre-Yves Revol, chairman of the Pierre Fabre Foundation; Eric Ducournau, group chief executive officer; Frédéric Duchesne, chief executive officer, pharmaceuticals; Eric Gouy, senior vice president, finance; Marc Alias, director, corporate communications; Thierry Denjean, senior vice president, human resources, ethics and sustainable development; Olivier Siegler, director of the digital, processes and organization corporate department; Michael Danon, senior vice president, legal, pharmaceutical and public affairs.
Major Products: Skin care and hair care. Brands Pierre Fabre, Ducray, Eau Thermale Avene, A-Derma, Klorane, Elancyl, Galenic, Rene Furterer, Darrow and Glytone. The company’s consumer health care division offers products relating to consumer health care, oral care and natural health, including phytotherapy and aromatherapy.
Comments: There’s a new person in the c-suite at Pierre Fabre Group; Eric Ducournau is now chief executive officer taking over for Bertrand Parmentier, who retired. Ducournau, who officially took over the post on July 2, had been CEO of Pierre Fabre Dermo-Cosmetics since October 2012. He joined the company in 2000.
This year, Pierre Fabre Dermo-Cosmetics signed a partnership in which it became the second investor in Même, a start-up brand that offers cosmetics for women suffering from cancer. The range—which was created by two young women inspired by their own personal experience—was formulated in collaboration with oncologists and dermatologists. According to Pierre Fabre, sales teams and medical reps of Eau Thermale Avène will help build recognition of Même products in oncology departments and pharmacies.
Last year, the Pierre Fabre group officially opened a renovated Péraudel site in Castres France, which is home to the group’s Consumer Health Care division. The unit, which is responsible for several OTC health products as well as oral care SKUs, natural health products, phytotherapy and aromatherapy, generated revenue of about $333 million in 2016. The renovation of the three-story building represented an investment of about $13 million.
Pierre Fabre’s clinical research and development center, located at the Hôtel-Dieu-Saint-Jacques in Toulouse, studies the physiology of normal skin and the biological, physico-chemical and mechanical mechanisms involved in skin disorders. Nearly 900 clinical studies are conducted at the site each year.
The Fabre name can be found on places other than skin care labs; the rugby stadium in Castres was recently renamed after Pierre Fabre, who was an avid fan of the sport.
In the US, the Klorane Botanical Foundation and national non-profit KidsGardening recently named six schools as winners of the inaugural Budding Botanist Grant. The grant, valued at $3000 in cash and supplies, is provided to school educators at inner city, low-income schools.
